Viewing Study NCT04837859


Ignite Creation Date: 2025-12-24 @ 3:00 PM
Ignite Modification Date: 2025-12-26 @ 5:23 PM
Study NCT ID: NCT04837859
Status: RECRUITING
Last Update Posted: 2024-07-26
First Post: 2021-04-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Trial of Individualized Immunotherapy in Early-Stage Unfavorable Classical Hodgkin Lymphoma
Sponsor: University of Cologne
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module